Defense Dept. Funds Ketamine Study For PTSD Treatment In 600 Service Members & Veterans

November 28, 2023

https://www.benzinga.com/markets/cannabis/23/11/35965889/defense-dept-funds-ketamine-study-for-ptsd-treatment-in-600-service-members-veterans

Defense Dept. Funds Ketamine Study For PTSD Treatment In 600 Service Members & Veterans
A Department of Defense (DOD) Health Agency-funded adaptive platform trial for alternative treatments for PTSD will test SLS-002 on some 600 active-duty service members and veterans.
https://www.benzinga.com/markets/cannabis/23/11/35965889/defense-dept-funds-ketamine-study-for-ptsd-treatment-in-600-service-members-veterans

Related news for (SEEL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.